Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Advances in Diabetes Management and Complications
This week's episode covers cutting-edge research in diabetes management, from continuous glucose monitoring to complications like neuropathy and nephropathy, plus exciting developments in GLP-1 therapies and prenatal interventions.
Bibliography
1. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Authors: Rodbard D
Journal: Diabetes technology & therapeutics, 2017 Jun
PMID: 28585879
DOI: 10.1089/dia.2017.0035
2. Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.
Authors: Ciudin A, Johansson E, Zimner-Rapuch S, et al.
Journal: Diabetes, obesity & metabolism, 2025 Sep
PMID: 40537987
DOI: 10.1111/dom.16508
3. A comprehensive definition for metabolic syndrome.
Authors: Huang PL
Journal: Disease models & mechanisms, 2009 May-Jun
PMID: 19407331
DOI: 10.1242/dmm.001180
4. Relationship between stress hyperglycaemic ratio (SHR) and critical illness: a systematic review.
Authors: Song G, Liu X, Lu Z, et al.
Journal: Cardiovascular diabetology, 2025 May 2
PMID: 40317019
DOI: 10.1186/s12933-025-02751-3
5. Challenges of neuropathic pain: focus on diabetic neuropathy.
Authors: Rosenberger DC, Blechschmidt V, Timmerman H, et al.
Journal: Journal of neural transmission (Vienna, Austria : 1996), 2020 Apr
PMID: 32036431
DOI: 10.1007/s00702-020-02145-7
6. Safety of Semaglutide.
Authors: Smits MM, Van Raalte DH
Journal: Frontiers in endocrinology, 2021
PMID: 34305810
DOI: 10.3389/fendo.2021.645563
7. Prenatal initiation of elexacaftor/tezacaftor/ivacaftor via carrier mother prevents congenital bilateral absence of vas deferens in a male infant with cystic fibrosis.
Authors: Thee S, Aleksander P, Lechner L, et al.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2026 Jul
PMID: 41654435
DOI: 10.1016/j.jcf.2026.02.001
8. Current status and progress in research on dressing management for diabetic foot ulcer.
Authors: Jiang P, Li Q, Luo Y, et al.
Journal: Frontiers in endocrinology, 2023
PMID: 37664860
DOI: 10.3389/fendo.2023.1221705
9. Epigenetics in the pathogenesis of diabetic nephropathy.
Authors: Li X, Lu L, Hou W, et al.
Journal: Acta biochimica et biophysica Sinica, 2022 Jan 25
PMID: 35130617
DOI: 10.3724/abbs.2021016
Authors: Rodbard D
Journal: Diabetes technology & therapeutics, 2017 Jun
PMID: 28585879
DOI: 10.1089/dia.2017.0035
2. Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.
Authors: Ciudin A, Johansson E, Zimner-Rapuch S, et al.
Journal: Diabetes, obesity & metabolism, 2025 Sep
PMID: 40537987
DOI: 10.1111/dom.16508
3. A comprehensive definition for metabolic syndrome.
Authors: Huang PL
Journal: Disease models & mechanisms, 2009 May-Jun
PMID: 19407331
DOI: 10.1242/dmm.001180
4. Relationship between stress hyperglycaemic ratio (SHR) and critical illness: a systematic review.
Authors: Song G, Liu X, Lu Z, et al.
Journal: Cardiovascular diabetology, 2025 May 2
PMID: 40317019
DOI: 10.1186/s12933-025-02751-3
5. Challenges of neuropathic pain: focus on diabetic neuropathy.
Authors: Rosenberger DC, Blechschmidt V, Timmerman H, et al.
Journal: Journal of neural transmission (Vienna, Austria : 1996), 2020 Apr
PMID: 32036431
DOI: 10.1007/s00702-020-02145-7
6. Safety of Semaglutide.
Authors: Smits MM, Van Raalte DH
Journal: Frontiers in endocrinology, 2021
PMID: 34305810
DOI: 10.3389/fendo.2021.645563
7. Prenatal initiation of elexacaftor/tezacaftor/ivacaftor via carrier mother prevents congenital bilateral absence of vas deferens in a male infant with cystic fibrosis.
Authors: Thee S, Aleksander P, Lechner L, et al.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2026 Jul
PMID: 41654435
DOI: 10.1016/j.jcf.2026.02.001
8. Current status and progress in research on dressing management for diabetic foot ulcer.
Authors: Jiang P, Li Q, Luo Y, et al.
Journal: Frontiers in endocrinology, 2023
PMID: 37664860
DOI: 10.3389/fendo.2023.1221705
9. Epigenetics in the pathogenesis of diabetic nephropathy.
Authors: Li X, Lu L, Hou W, et al.
Journal: Acta biochimica et biophysica Sinica, 2022 Jan 25
PMID: 35130617
DOI: 10.3724/abbs.2021016
